Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children

Diabetes Technology and Therapeutics

Volumn 13, Issue 12, 2011, Pages 1187-1193

  Zucchini, Stefano ^a   Scipione, Mirella ^a   Balsamo, Claudia ^a   Maltoni, Giulio ^a   Rollo, Alessandra ^a   Molinari, Emanuela ^b   Mangoni, Lorenza ^b   Cicognani, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Clinical Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO;

ACCURACY; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SENSOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; AREA UNDER CURVE; BLOOD GLUCOSE; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 82455213038     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0080     Document Type: Article

References (28)

1. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010;(1):CD005103.
2. McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP: A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 2006;8:644-653. (Pubitemid 44871494)
3. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH: Glucose variability; does it matter? Endocr Rev 2010;31:171-182.
4. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
5. Ceriello A, Ihnat M: 'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. Diabet Med 2010;27:862-867.
6. Hirsch IB, Brownlee M: Beyond hemoglobin A1c-need for additional markers of risk for diabetic microvascular complications. JAMA 2010;303:2291-2292.
7. Vaddiraju S, Burgess DJ, Tomazos I, Jain FC, Papadimitrakopoulos F: Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol 2010;4:1540-1562.
8. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
9. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
10. Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T: Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 2010;53:2487-2495.
11. Conget I, Battelino T, Gimenez M, Gough H, Castaneda J, Bolinder J; SWITCH Study Group: The SWITCH study (Sensing With Insulin pump Therapy to Control HbA1c): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technol Ther 2011;13:49-54.
12. Simon B, Treat V,Marco C, Rosenberg D, Joseph J,Hipszer B, Li Y, Chervoneva I, Padron-Massara L, Jabbour S: A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. Int J Clin Pract 2008;62:1858-1863.
13. Garg SK, Voelmle MK, Beatson CR, Miller HA, Crew LB, Freson BJ, Hazenfield RM: Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-months study. Diabetes Care 2011; 34:574-579.
14. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ: A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005; 7:253-263. (Pubitemid 40586369)
15. Kovatchev B, Clarke WL, Breton M, Brayman K, McCall A: Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther 2005;7:849-862. (Pubitemid 43133992)
16. Service FJ, Molnar O, Jersild M: Mean amplitude of the largest glycaemic excursions (MAGE)-a measure of glycaemic instability. Diabetes 1970;19:644-655.
17. Kovatchev BP, Cox DJ, Gonder-FrederickLA, Young-Hyman D, Schlundt D, ClarkeWL: Assessment of risk for severe hypoglycaemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 1998;21:1870-1875. (Pubitemid 28478285)
18. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke WL: Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care 1997;20:1655-1658. (Pubitemid 27463037)
19. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group: Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478.
20. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;15;287:2563-2569.
21. Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E: The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA1c in pediatric type 1 diabetic patients. Diabetes Care 2002;25:1840-1844. (Pubitemid 41071097)
22. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N; American Diabetes Association: Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005; 28:186-212. (Pubitemid 40095803)
23. Wentholt IEM, Kulik W, Michels RPJ, Hoekstra JBL, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008;51:183-190. (Pubitemid 50002199)
24. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK: Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009;11:717-723.
25. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34: 795-800.
26. Mastrototaro J, Shin J, Marcus A, Sulur G; STAR 1 Clinical Trial Investigators: The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther 2008;10:385-390.
27. Davey RJ, Jones TW, Fournier PA: Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus. J Diabetes Sci Technol 2010;4:1457-1464.
28. Keenan DB, Cartaya R, Mastrototaro JJ: Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sci Technol 2010;4:111-118.